Form 4 for HLT Hilton Worldwide
Accepted 2026-02-19 00:00:00 ET · period of report 2026-02-17 · accession 0001078095-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-19 | 2026-02-17 | HLT | NASSETTA CHRISTOPHER J | See Remarks, Dir | S - Sale+OE | $317.47 | -114.3K | 120.3K | -49% | -$36.28M |
| D | 2026-02-19 | 2026-02-17 | HLT | NASSETTA CHRISTOPHER J | See Remarks, Dir | M - OptEx | $41.41 | +114.3K | 150.7K | +314% | +$4.73M |
| D | 2026-02-19 | 2026-02-17 | HLT | NASSETTA CHRISTOPHER J | See Remarks, Dir | M - OptEx | $0.00 | -114.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-17 | S | D | 27,376 | $318.37 | 45,820 | D | — | — | (F1) Includes shares sold to cover payment of option exercise price and payment of tax liability incident to exercise of option granted in February 2016 that expires on February 18, 2026. (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $317.86 to $318.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 2 | Common | Common Stock | 2026-02-17 | S | D | 9,375 | $319.30 | 36,445 | D | — | — | (F1) Includes shares sold to cover payment of option exercise price and payment of tax liability incident to exercise of option granted in February 2016 that expires on February 18, 2026. (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $318.86 to $319.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. |
| 3 | Common | Common Stock | 2026-02-17 | M | A | 114,289 | $41.41 | 150,734 | D | — | — | |
| 4 | Common | Common Stock | 2026-02-17 | S | D | 47,134 | $317.36 | 73,196 | D | — | — | (F1) Includes shares sold to cover payment of option exercise price and payment of tax liability incident to exercise of option granted in February 2016 that expires on February 18, 2026. (F3) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $316.86 to $317.8575, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. |
| 5 | Common | Common Stock | 2026-02-17 | S | D | 30,404 | $316.27 | 120,330 | D | — | — | (F1) Includes shares sold to cover payment of option exercise price and payment of tax liability incident to exercise of option granted in February 2016 that expires on February 18, 2026. (F2) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $315.86 to $316.8475, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above. |
| 6 | Derivative | Employee Stock Option (right to buy) | 2026-02-17 | M | D | 114,289 | $0.00 | 0 | D | $41.41 · — to 2026-02-18 | 114,289 Common Stock | (F8) The option vested in three equal annual installments beginning on February 18, 2017. |